Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyethylene glycol loxenatide with or without whey protein in adults with obesity
ChiCTR2500096571Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol loxenatide in obesity (4 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: body weight. Started Jan 2025; status: completed.
02
Drugs
polyethylene glycol loxenatide
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2500096571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096571.